Xiaodong Ma Selected Research

schizandrin C

10/2022

SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous Cap as potential immunomodulatory agents for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodong Ma Research Topics

Disease

54	Neoplasms (Cancer) 10/2022 - 08/2007
21	Inflammation (Inflammations) 01/2022 - 01/2015
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020 - 01/2016
11	Lung Neoplasms (Lung Cancer) 10/2021 - 01/2015
8	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 01/2017
8	Fibrosis (Cirrhosis) 03/2022 - 03/2018
7	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 01/2017
7	Glioma (Gliomas) 01/2022 - 07/2015
7	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 01/2018
7	Carcinogenesis 01/2019 - 06/2011
6	Non-alcoholic Fatty Liver Disease 08/2022 - 07/2017
6	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2015
5	Cholestasis 08/2019 - 12/2017
4	Lymphoma (Lymphomas) 01/2021 - 07/2017
4	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2019
4	Insulin Resistance 02/2019 - 07/2017
3	Pathologic Processes 11/2022 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 08/2007
3	Stroke (Strokes) 01/2022 - 01/2019
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 12/2020 - 06/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2020 - 10/2019
3	Idiopathic Pulmonary Fibrosis 09/2020 - 01/2020
3	Multiple Myeloma 01/2019 - 11/2014
3	Body Weight (Weight, Body) 01/2019 - 09/2013
3	Liver Diseases (Liver Disease) 04/2018 - 12/2017
2	Spasm (Spasms) 01/2022 - 01/2022
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2022
2	Pain (Aches) 01/2022 - 10/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2021 - 01/2020
2	Ischemic Stroke 01/2021 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 08/2020 - 06/2011

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 10/2022 - 06/2011
13	Biological ProductsIBA 11/2021 - 06/2011
11	Pharmaceutical PreparationsIBA 10/2021 - 11/2016
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2015
7	Gefitinib (Iressa)FDA Link 01/2021 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2013
5	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 01/2017
5	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2015
5	dioscinIBA 10/2019 - 01/2017
5	Estrogens (Estrogen)FDA Link 10/2019 - 09/2015
5	yangoninIBA 10/2019 - 01/2018
5	Bile Acids and Salts (Bile Acids)IBA 08/2019 - 01/2018
5	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2019 - 07/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2006
4	ibrutinibIBA 01/2021 - 01/2018
4	pyrimidineIBA 01/2020 - 01/2018
4	EnzymesIBA 01/2020 - 11/2016
4	LipidsIBA 10/2019 - 07/2017
4	Interleukin-6 (Interleukin 6)IBA 10/2018 - 01/2017
3	CeruletideIBA 03/2022 - 05/2015
3	Phosphocreatine (Neoton)IBA 02/2022 - 01/2018
3	LigandsIBA 01/2022 - 04/2016
3	Insulin (Novolin)FDA Link 01/2022 - 02/2018
3	ProdrugsIBA 10/2021 - 01/2019
3	Amino Acids FDA Link 01/2021 - 11/2014
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2020
3	CollagenIBA 01/2021 - 10/2019
3	AntioxidantsIBA 09/2020 - 08/2007
3	MicellesIBA 09/2020 - 11/2019
3	Chimeric Antigen ReceptorsIBA 08/2020 - 01/2018
3	spebrutinibIBA 01/2020 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2017
3	2,6-dinitrotoluene (DNT)IBA 01/2019 - 01/2019
3	Streptozocin (Streptozotocin)FDA Link 01/2019 - 11/2013
3	ResveratrolIBA 01/2019 - 08/2007
3	ErbB Receptors (EGF Receptor)IBA 12/2018 - 04/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2018 - 07/2016
3	HMGB1 Protein (HMG1)IBA 03/2018 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2018 - 01/2015
3	QuinazolinesIBA 01/2018 - 01/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 07/2017 - 01/2017
2	formononetinIBA 09/2022 - 01/2017
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2022 - 07/2017
2	Gemcitabine FDA Link 07/2022 - 10/2021
2	Neuroprotective AgentsIBA 02/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2020
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2020 - 01/2019
2	DisulfidesIBA 12/2020 - 01/2019
2	FenretinideIBA 10/2020 - 09/2020
2	TOR Serine-Threonine KinasesIBA 09/2020 - 02/2017
2	CytokinesIBA 08/2020 - 01/2015
2	AntigensIBA 08/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 12/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2020 - 01/2018
2	rheinIBA 01/2020 - 09/2018
2	Cilastatin FDA Link 01/2020 - 09/2019
2	Organic Anion TransportersIBA 01/2020 - 07/2018
2	Cytochromes c (Cytochrome c)IBA 01/2020 - 08/2007

Therapy/Procedure

25	Therapeutics 10/2022 - 06/2011
6	Drug Therapy (Chemotherapy) 07/2022 - 07/2016
3	Immunotherapy 01/2020 - 01/2018
3	Brachytherapy 06/2019 - 09/2017
3	Stents 03/2011 - 07/2010